Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Janssen Pharmaceutical Companies of Johnson & Johnson - Expanding the therapeutic opportunities in advanced prostate cancer

Optimising therapeutic strategies in mHSPC

Date

29 Sep 2019

Session

Janssen Pharmaceutical Companies of Johnson & Johnson - Expanding the therapeutic opportunities in advanced prostate cancer

Presenters

Alvaro Pinto Marin

Authors

K.N. Chi1, A. Pinto Marin2

Author affiliations

  • 1 Medical Oncology, BC Cancer Agency - Vancouver, V5Z 4E6 - Vancouver/CA
  • 2 Medical Oncology, Hospital Universitario La Paz, 28046 - Madrid/ES
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings